Literature DB >> 21241795

Ketamine anesthesia during the first week of life can cause long-lasting cognitive deficits in rhesus monkeys.

M G Paule1, M Li, R R Allen, F Liu, X Zou, C Hotchkiss, J P Hanig, T A Patterson, W Slikker, C Wang.   

Abstract

Previously our laboratory has shown that ketamine exposure (24h of clinically relevant anesthesia) causes significant increases in neuronal cell death in perinatal rhesus monkeys. Sensitivity to this ketamine-induced neurotoxicity was observed on gestational days 120-123 (in utero exposure via maternal anesthesia) and on postnatal days (PNDs) 5-6, but not on PNDs 35-37. In the present study, six monkeys were exposed on PND 5 or 6 to intravenous ketamine anesthesia to maintain a light surgical plane for 24h and six control animals were unexposed. At 7 months of age all animals were weaned and began training to perform a series of cognitive function tasks as part of the National Center for Toxicological Research (NCTR) Operant Test Battery (OTB). The OTB tasks used here included those for assessing aspects of learning, motivation, color discrimination, and short-term memory. Subjects responded for banana-flavored food pellets by pressing response levers and press-plates during daily (M-F) test sessions (50 min) and were assigned training scores based upon their individual performance. As reported earlier (Paule et al., 2009) beginning around 10 months of age, control animals significantly outperformed (had higher training scores than) ketamine-exposed animals for approximately the next 10 months. For animals now over 3 and one-half years of age, the cognitive impairments continue to manifest in the ketamine-exposed group as poorer performance in the OTB learning and color and position discrimination tasks, as deficits in accuracy of task performance, but also in response speed. There are also apparent differences in the motivation of these animals which may be impacting OTB performance. These observations demonstrate that a single 24-h episode of ketamine anesthesia, occurring during a sensitive period of brain development, results in very long-lasting deficits in brain function in primates and provide proof-of-concept that general anesthesia during critical periods of brain development can result in subsequent functional deficits. Supported by NICHD, CDER/FDA and NCTR/FDA. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21241795      PMCID: PMC3071878          DOI: 10.1016/j.ntt.2011.01.001

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  76 in total

Review 1.  Neurotransmitters and apoptosis in the developing brain.

Authors:  C Ikonomidou; P Bittigau; C Koch; K Genz; F Hoerster; U Felderhoff-Mueser; T Tenkova; K Dikranian; J W Olney
Journal:  Biochem Pharmacol       Date:  2001-08-15       Impact factor: 5.858

Review 2.  Functional consequences of changes in NMDA receptor subunit expression during development.

Authors:  D Feldmeyer; S Cull-Candy
Journal:  J Neurocytol       Date:  1996-12

3.  Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brain.

Authors:  Chainllie Young; Vesna Jevtovic-Todorovic; Yue-Qin Qin; Tatyana Tenkova; Haihui Wang; Joann Labruyere; John W Olney
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

4.  Isoflurane-induced neuroapoptosis in the neonatal rhesus macaque brain.

Authors:  Ansgar M Brambrink; Alex S Evers; Michael S Avidan; Nuri B Farber; Derek J Smith; Xuezhao Zhang; Gregory A Dissen; Catherine E Creeley; John W Olney
Journal:  Anesthesiology       Date:  2010-04       Impact factor: 7.892

Review 5.  Use of anesthetic agents in neonates and young children.

Authors:  R Daniel Mellon; Arthur F Simone; Bob A Rappaport
Journal:  Anesth Analg       Date:  2007-03       Impact factor: 5.108

6.  Effect of prolonged ketamine exposure on cardiovascular physiology in pregnant and infant rhesus monkeys (Macaca mulatta).

Authors:  Charlotte E Hotchkiss; Cheng Wang; William Slikker
Journal:  J Am Assoc Lab Anim Sci       Date:  2007-11       Impact factor: 1.232

7.  The effects of L-carnitine on the combination of, inhalation anesthetic-induced developmental, neuronal apoptosis in the rat frontal cortex.

Authors:  X Zou; N Sadovova; T A Patterson; R L Divine; C E Hotchkiss; S F Ali; J P Hanig; M G Paule; W Slikker; C Wang
Journal:  Neuroscience       Date:  2007-12-15       Impact factor: 3.590

Review 8.  The enigma of fetal alcohol neurotoxicity.

Authors:  John W Olney; David F Wozniak; Nuri B Farber; Vesna Jevtovic-Todorovic; Petra Bittigau; Chrysanthy Ikonomidou
Journal:  Ann Med       Date:  2002       Impact factor: 4.709

Review 9.  Beyond anesthetic properties: the effects of isoflurane on brain cell death, neurogenesis, and long-term neurocognitive function.

Authors:  Greg Stratmann; Jeffrey W Sall; Laura D V May; Andreas W Loepke; Michael T Lee
Journal:  Anesth Analg       Date:  2010-02       Impact factor: 5.108

Review 10.  Environmental agents that have the potential to trigger massive apoptotic neurodegeneration in the developing brain.

Authors:  J W Olney; N B Farber; D F Wozniak; V Jevtovic-Todorovic; C Ikonomidou
Journal:  Environ Health Perspect       Date:  2000-06       Impact factor: 9.031

View more
  191 in total

Review 1.  Anesthetic-related neurotoxicity and the developing brain: shall we change practice?

Authors:  Laszlo Vutskits
Journal:  Paediatr Drugs       Date:  2012-02-01       Impact factor: 3.022

2.  Attention-deficit/hyperactivity disorder after early exposure to procedures requiring general anesthesia.

Authors:  Juraj Sprung; Randall P Flick; Slavica K Katusic; Robert C Colligan; William J Barbaresi; Katarina Bojanić; Tasha L Welch; Michael D Olson; Andrew C Hanson; Darrell R Schroeder; Robert T Wilder; David O Warner
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

3.  Altered Mitochondrial Dynamics Contributes to Propofol-induced Cell Death in Human Stem Cell-derived Neurons.

Authors:  Danielle M Twaroski; Yasheng Yan; Ivan Zaja; Eric Clark; Zeljko J Bosnjak; Xiaowen Bai
Journal:  Anesthesiology       Date:  2015-11       Impact factor: 7.892

4.  Comparative Risk of Human Injury/Exposure While Collecting Blood from Sedated and Unsedated Nonhuman Primates.

Authors:  Charlotte E Hotchkiss; Melinda A Young
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-06-11       Impact factor: 1.232

5.  Estimating pediatric general anesthesia exposure: Quantifying duration and risk.

Authors:  Devan Darby Bartels; Mary Ellen McCann; Andrew J Davidson; David M Polaner; Elizabeth L Whitlock; Brian T Bateman
Journal:  Paediatr Anaesth       Date:  2018-05-02       Impact factor: 2.556

6.  Using animal models to evaluate the functional consequences of anesthesia during early neurodevelopment.

Authors:  Susan E Maloney; Catherine E Creeley; Richard E Hartman; Carla M Yuede; Charles F Zorumski; Vesna Jevtovic-Todorovic; Krikor Dikranian; Kevin K Noguchi; Nuri B Farber; David F Wozniak
Journal:  Neurobiol Learn Mem       Date:  2018-03-14       Impact factor: 2.877

7.  Juvenile exposure to ketamine causes delayed emergence of EEG abnormalities during adulthood in mice.

Authors:  R E Featherstone; L R Nagy; C G Hahn; S J Siegel
Journal:  Drug Alcohol Depend       Date:  2013-09-27       Impact factor: 4.492

Review 8.  Neurogenesis and developmental anesthetic neurotoxicity.

Authors:  Eunchai Kang; Daniel A Berg; Orion Furmanski; William M Jackson; Yun Kyoung Ryu; Christy D Gray; C David Mintz
Journal:  Neurotoxicol Teratol       Date:  2016-10-14       Impact factor: 3.763

Review 9.  General Anesthetics and Neurotoxicity: How Much Do We Know?

Authors:  Vesna Jevtovic-Todorovic
Journal:  Anesthesiol Clin       Date:  2016-09

10.  Role of mitochondrial complex I and protective effect of CoQ10 supplementation in propofol induced cytotoxicity.

Authors:  Christian Bergamini; Noah Moruzzi; Francesco Volta; Laura Faccioli; Jantje Gerdes; Maria Cristina Mondardini; Romana Fato
Journal:  J Bioenerg Biomembr       Date:  2016-08-15       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.